NJV

Test, Albumin Cobalt Binding

Product code
NJV
Device name
Test, Albumin Cobalt Binding
Device class
Class 2
21 CFR
21 CFR 862.1215
Medical specialty
Clinical Chemistry
Marketing pathway
510(K)
Flag
Third-party review eligible
510(k) clearances (all years, FDA)
2 (all years; only the last 3 years are listed here)

FDA classification definition

The Albumin Cobalt Binding Test is a quantitative in vitro diagnostic test used on human serum that detects Ischemia Modified Albumin by measuring the cobalt binding capacity of albumin in human serum. IMA is intended for use in conjunction with other tests such as ECG and cardiac troponin as an aid to the short term risk stratification of patients presenting with chest pain suggestive of cardiac origin.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

Official FDA classification page: NJV
Classification and pathway per current FDA publications. Data from openFDA (CC0).